Tumor-Infiltrating Lymphocyte Cancer Therapy Nears FDA Finish Line

By
Noshin Noorjahan
-
0
245
The FDA could soon approve Iovance’s lifileucel for advanced melanoma, a much-anticipated milestone for the 35-year-old T cell therapy modality.
[Nature Reviews Drug Discovery]
Full Article